NASDAQ:CMMB   Chemomab Therapeutics Ltd.
I think Chemomab Therapeutics Ltd (NASDAQ:CMMB) is building a nice base for take off. Some technical indicators are showing positive divergences on a daily basis. We could be in the early stages of a nice rally for this stock. Keep a close eye on it going forward. The stock currently trades at just over $18 a share, but analysts have targets pegged as high as $45 a share, suggesting as much as 120% upside.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.